Brief: Sio Gene Therapies Posts Q3 Loss Per Share $0.20

Sio Gene Therapies

09/02/2021 12:13

Feb 9 (Reuters) - Sio Gene Therapies Inc  SIOX.O :
    * SIO GENE THERAPIES ANNOUNCES FINANCIAL RESULTS FOR THIRD
FISCAL
QUARTER ENDED DECEMBER 31, 2020
    * Q3 LOSS PER SHARE $0.20
    * Q3 EARNINGS PER SHARE ESTIMATE $-0.29 -- REFINITIV IBES
DATA
    * CASH RUNWAY EXPECTED INTO SECOND CALENDAR QUARTER OF 2022
    * EXPECTS TO RECEIVE ADDITIONAL $16 MILLION IN CASH IN 2021
FROM
SALE OF ARVELLE THERAPEUTICS SHARES
    * AS OF DECEMBER 31, 2020, WE HAD $81.0 MILLION OF CASH AND
CASH
EQUIVALENTS

Source text for Eikon:  ID:nGNX7DVWj9 
Further company coverage:  SIOX.O 

 ((Reuters.Briefs@thomsonreuters.com;))